04-03-2022
Latest In Brief
- InBriefBRIEF—Bayer appoints head of US government and industry affairs group
07-03-2022
- InBriefBRIEF—UK PIM designation for rezafungin in invasive candidiasis
04-03-2022
- InBriefBRIEF—ICER to assess treatments for obesity management
04-03-2022
- InBriefBRIEF—Cayuga Biotech appoints new chief executive
04-03-2022
Latest Pharmaceutical News
Chemglass CV-1350-0010 Series CV-1350 96-Well Microplate Sealing
07-03-2022
Global drugmakers have no plans to leave Russia, aiming to continue their work in the local market despite…
- ArticleJardiance now force to be reckoned with in heart failure
07-03-2022
- ArticleNew Phase III data support regulatory filing for fezolinetant
07-03-2022
- ArticleEuropean pharma industry affirms efforts to avoid animal testing
07-03-2022
- ArticleSanofi calls on FDA to review competitor’s flu vaccine labelling
07-03-2022
Latest Biotechnology News
Moderna investing up to $500 million to produce vaccines for African continent
07-03-2022
US mRNA therapeutics and vaccines developer Moderna today announced that, with the assistance of the…
- ArticleWith wings clipped by FDA delay, bluebird's future is in doubt
07-03-2022
- ArticleFiling for additional Gazyva indication of CLL in Japan
07-03-2022
- ArticlePak of 2 Dial Burner Knob DG64-00347A for Samsung Range Oven NX5
07-03-2022
- Article$67 million funding round for Microbiotica
07-03-2022
Latest Generics News
“Better patient access to medicines and restoring Europe’s security of supply more critical than ever”
07-03-2022
The COVID-19 pandemic has highlighted the critical link between patient access to medicine and a robust…
- ArticleCivica Rx to manufacture and distribute affordable insulin
04-03-2022
- ArticleInclude essential medicines in EU industrial policy plans, trade group says
03-03-2022
- ArticleApprovals for Lotus Pharma’s generics in the Philippines
02-03-2022
- ArticleHikma delivers another year of profitable growth in 2021
24-02-2022
Latest Biosimilars News
Hanchen 10pcs Commercial Waffle Maker NP-533 Electric Waffle Mac
ArticleBiocon Biologics buys biosimilars business of Viatris for $3.3 billion
28-02-2022
Biocon subsidiary Biocon Biologics has agreed to buy the biosimilars unit of Viatris for $3.3 billion.
- ArticleFDA accepts Pfizer’s sBLA for Abrilada interchangeability
26-02-2022
- ArticlePositive new data on Celltrion’s Remsima biosimilar
21-02-2022
- ArticleIndian drugmakers seek to capitalize on US and other bids to lower cost
17-02-2022
- ArticleBiogen and Xbrane link up on Cimzia biosimilar
10-02-2022